SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4y9v'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1G60_A_SAMA500_0 (ADENINE-SPECIFIC METHYLTRANSFERASE MBOIIA)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	5 / 12	CYH A 467 ASP A 437 GLY A 435 SER A 429 THR A 433	None SO4 A 809 ( 4.7A) None None None	1.28A	1g60A-4y9vA: undetectable	1g60A-4y9vA: 17.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GEB_A_CAMA418_0 (CYTOCHROME P450-CAM)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	5 / 9	PHE A 194 LEU A 179 ILE A 164 VAL A 188 ILE A 192	None	1.34A	1gebA-4y9vA: undetectable	1gebA-4y9vA: 19.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HTT_D_HISD450_0 (HISTIDYL-TRNA SYNTHETASE)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	5 / 12	THR A 456 ARG A 268 ARG A 401 GLY A 435 ALA A 405	None SO4 A 809 ( 3.1A) SO4 A 809 (-2.9A) None None	1.04A	1httD-4y9vA: undetectable	1httD-4y9vA: 21.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KF6_N_ACTN803_0 (FUMARATE REDUCTASE FLAVOPROTEIN FUMARATE REDUCTASE IRON-SULFUR PROTEIN)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	4 / 6	ARG A 357 GLY A 410 ASP A 409 TYR A 257	None 49T A 815 ( 4.5A) None None	1.45A	1kf6M-4y9vA: undetectable 1kf6N-4y9vA: undetectable	1kf6M-4y9vA: 21.58 1kf6N-4y9vA: 16.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LH6_A_NIOA155_1 (LEGHEMOGLOBIN A (NICOTINATE MET))	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	4 / 7	PHE A 198 PHE A 200 PHE A 208 VAL A 171	None	1.01A	1lh6A-4y9vA: undetectable	1lh6A-4y9vA: 14.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1LH6_A_NIOA155_1 (LEGHEMOGLOBIN A (NICOTINATE MET))	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	4 / 7	PHE A 200 PHE A 208 PHE A 216 VAL A 171	None	0.98A	1lh6A-4y9vA: undetectable	1lh6A-4y9vA: 14.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1NW5_A_SAMA401_0 (MODIFICATION METHYLASE RSRI)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	5 / 12	ASP A 568 PRO A 500 GLY A 537 VAL A 539 ALA A 569	None	1.31A	1nw5A-4y9vA: undetectable	1nw5A-4y9vA: 19.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CIZ_A_ACTA1321_0 (CHLOROPEROXIDASE)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	4 / 5	LEU A 427 ASN A 397 VAL A 422 ALA A 425	None	1.19A	2cizA-4y9vA: undetectable	2cizA-4y9vA: 19.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DCF_A_ACAA502_1 (6-AMINOHEXANOATE-DIM ER HYDROLASE)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	5 / 12	ALA A 403 TYR A 392 VAL A 422 GLY A 381 ILE A 382	None	1.21A	2dcfA-4y9vA: undetectable	2dcfA-4y9vA: 20.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FQY_A_ADNA400_1 (MEMBRANE LIPOPROTEIN TMPC)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	5 / 12	ASP A 461 PHE A 488 GLY A 460 MET A 438 VAL A 478	EDO A 802 (-4.0A) None EDO A 802 ( 3.8A) None None	1.39A	2fqyA-4y9vA: undetectable	2fqyA-4y9vA: 21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JFA_B_CCSB417_0 (ESTROGEN RECEPTOR)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	3 / 3	GLN A 170 LYS A 172 VAL A 176	EDO A 804 (-4.1A) None EDO A 808 ( 3.6A)	0.75A	2jfaB-4y9vA: undetectable	2jfaB-4y9vA: 15.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2LH6_A_NIOA155_1 (LEGHEMOGLOBIN A (NICOTINATE MET))	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	4 / 5	PHE A 198 PHE A 200 PHE A 208 VAL A 171	None	1.02A	2lh6A-4y9vA: undetectable	2lh6A-4y9vA: 14.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VL2_A_BEZA1162_0 (PEROXIREDOXIN-5)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	5 / 10	THR A 497 GLY A 476 LEU A 570 PHE A 567 GLY A 537	None	1.31A	2vl2A-4y9vA: undetectable 2vl2C-4y9vA: undetectable	2vl2A-4y9vA: 14.22 2vl2C-4y9vA: 14.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZJ0_C_2FAC500_2 (ADENOSYLHOMOCYSTEINA SE)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	4 / 5	LEU A 501 THR A 497 THR A 540 HIS A 572	None	1.32A	2zj0C-4y9vA: undetectable	2zj0C-4y9vA: 21.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A65_A_ACAA601_1 (6-AMINOHEXANOATE-DIM ER HYDROLASE)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	5 / 12	ALA A 403 TYR A 392 VAL A 422 GLY A 381 ILE A 382	None	1.37A	3a65A-4y9vA: undetectable	3a65A-4y9vA: 20.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3APV_A_TP0A190_1 (ALPHA-1-ACID GLYCOPROTEIN 2)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	5 / 12	VAL A 176 PHE A 216 PHE A 208 LEU A 318 HIS A 180	EDO A 808 ( 3.6A) None None None EDO A 805 (-4.6A)	1.37A	3apvA-4y9vA: undetectable	3apvA-4y9vA: 14.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3APV_B_TP0B190_1 (ALPHA-1-ACID GLYCOPROTEIN 2)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	5 / 12	VAL A 176 PHE A 216 PHE A 208 LEU A 318 HIS A 180	EDO A 808 ( 3.6A) None None None EDO A 805 (-4.6A)	1.36A	3apvB-4y9vA: undetectable	3apvB-4y9vA: 14.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EKP_B_478B200_2 (PROTEASE)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	5 / 10	LEU A 354 VAL A 404 GLY A 394 ALA A 369 ILE A 382	None	0.97A	3ekpB-4y9vA: undetectable	3ekpB-4y9vA: 8.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EL0_A_1UNA201_2 (PROTEASE)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	5 / 9	LEU A 354 VAL A 404 GLY A 394 ALA A 369 ILE A 382	None	1.02A	3el0B-4y9vA: undetectable	3el0B-4y9vA: 8.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IK6_B_HCZB262_1 (GLUTAMATE RECEPTOR 2)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	5 / 10	ILE A 724 PRO A 656 SER A 722 GLY A 723 LYS A 654	None	1.31A	3ik6B-4y9vA: undetectable 3ik6E-4y9vA: undetectable	3ik6B-4y9vA: 16.01 3ik6E-4y9vA: 16.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IK6_B_HCZB800_1 (GLUTAMATE RECEPTOR 2)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	5 / 10	LYS A 654 ILE A 724 PRO A 656 SER A 722 GLY A 723	None	1.28A	3ik6B-4y9vA: undetectable 3ik6E-4y9vA: undetectable	3ik6B-4y9vA: 16.01 3ik6E-4y9vA: 16.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OWX_A_XRAA233_2 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE [QUINONE])	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	4 / 5	VAL A 304 PHE A 240 ILE A 232 PHE A 289	None	1.13A	3owxB-4y9vA: undetectable	3owxB-4y9vA: 16.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SUF_B_SUEB1201_3 (NS3 PROTEASE, NS4A PROTEIN)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	4 / 5	SER A 385 PRO A 416 TYR A 271 VAL A 415	None	1.41A	3sufC-4y9vA: undetectable	3sufC-4y9vA: 16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TWP_A_SALA404_1 (ANTHRANILATE PHOSPHORIBOSYLTRANSF ERASE)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	4 / 7	ASN A 598 ALA A 603 PRO A 605 ARG A 571	None	1.08A	3twpA-4y9vA: undetectable	3twpA-4y9vA: 21.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MMD_A_29EA603_1 (TRANSPORTER)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	5 / 10	VAL A 404 ALA A 405 GLY A 420 SER A 385 GLY A 407	None None None None 49S A 814 (-3.5A)	1.22A	4mmdA-4y9vA: undetectable	4mmdA-4y9vA: 20.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MMD_B_29EB603_1 (TRANSPORTER)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	5 / 12	VAL A 404 ALA A 405 GLY A 420 SER A 385 GLY A 407	None None None None 49S A 814 (-3.5A)	1.19A	4mmdB-4y9vA: undetectable	4mmdB-4y9vA: 20.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N48_B_SAMB601_1 (CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	4 / 5	ASN A 441 GLY A 407 ASP A 448 ASP A 437	49S A 814 (-3.6A) 49S A 814 (-3.5A) None SO4 A 809 ( 4.7A)	1.15A	4n48B-4y9vA: undetectable	4n48B-4y9vA: 22.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N49_A_SAMA601_1 (CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-M ETHYLTRANSFERASE 1)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	4 / 4	ASN A 441 GLY A 407 ASP A 448 ASP A 437	49S A 814 (-3.6A) 49S A 814 (-3.5A) None SO4 A 809 ( 4.7A)	1.12A	4n49A-4y9vA: undetectable	4n49A-4y9vA: 22.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WOZ_B_MN9B401_0 (N-ACETYLNEURAMINATE LYASE)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	4 / 6	THR A 206 LEU A 149 ASP A 150 LEU A 179	None None EDO A 807 ( 3.6A) None	0.74A	4wozA-4y9vA: undetectable 4wozB-4y9vA: undetectable	4wozA-4y9vA: 18.28 4wozB-4y9vA: 18.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WOZ_F_MN9F401_0 (N-ACETYLNEURAMINATE LYASE)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	4 / 5	LEU A 149 ASP A 150 LEU A 179 THR A 206	None EDO A 807 ( 3.6A) None None	0.75A	4wozF-4y9vA: undetectable 4wozH-4y9vA: undetectable	4wozF-4y9vA: 18.28 4wozH-4y9vA: 18.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XE5_A_OBNA1104_2 (SODIUM/POTASSIUM-TRA NSPORTING ATPASE SUBUNIT ALPHA-1)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	4 / 6	PRO A 483 ILE A 510 VAL A 576 ARG A 472	None	1.07A	4xe5A-4y9vA: undetectable	4xe5A-4y9vA: 20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XUM_A_IMNA501_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	5 / 12	ILE A 311 PHE A 362 LEU A 356 LEU A 354 LEU A 331	EDO A 803 (-4.6A) None None None None	1.32A	4xumA-4y9vA: undetectable	4xumA-4y9vA: 17.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y8W_C_STRC603_1 (CYTOCHROME P450 21-HYDROXYLASE)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	5 / 12	SER A 505 TRP A 575 ILE A 591 ILE A 541 GLY A 509	None	0.93A	4y8wC-4y9vA: undetectable	4y8wC-4y9vA: 20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KQX_A_ROCA101_2 (PROTEASE E35D-SQV)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	5 / 9	LEU A 354 VAL A 404 GLY A 395 ILE A 366 ILE A 382	None	1.13A	5kqxB-4y9vA: undetectable	5kqxB-4y9vA: 9.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OEX_A_CUA601_0 (THIOCYANATE DEHYDROGENASE)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	3 / 3	HIS A 439 ASP A 437 HIS A 402	49S A 814 ( 3.4A) SO4 A 809 ( 4.7A) SO4 A 809 (-3.9A)	0.71A	5oexA-4y9vA: undetectable	5oexA-4y9vA: 21.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OEX_B_CUB601_0 (THIOCYANATE DEHYDROGENASE)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	3 / 3	HIS A 439 ASP A 437 HIS A 402	49S A 814 ( 3.4A) SO4 A 809 ( 4.7A) SO4 A 809 (-3.9A)	0.74A	5oexB-4y9vA: undetectable	5oexB-4y9vA: 21.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OEX_D_CUD601_0 (THIOCYANATE DEHYDROGENASE)	4y9v	PARTICLE-ASSOCIATED LYASE (Acinetobacter virus AP22)	3 / 3	HIS A 439 ASP A 437 HIS A 402	49S A 814 ( 3.4A) SO4 A 809 ( 4.7A) SO4 A 809 (-3.9A)	0.76A	5oexD-4y9vA: undetectable	5oexD-4y9vA: 21.36

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1G60_A_SAMA500_0","ADENINE-SPECIFIC METHYLTRANSFERASE MBOIIA","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",5,"CYH A 467;ASP A 437;GLY A 435;SER A 429;THR A 433","None;SO4 A 809 ( 4.7A);None;None;None","1.28A","1g60A-4y9vA:undetectable","1g60A-4y9vA:17.24"],["1GEB_A_CAMA418_0","CYTOCHROME P450-CAM","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",5,"PHE A 194;LEU A 179;ILE A 164;VAL A 188;ILE A 192","None","1.34A","1gebA-4y9vA:undetectable","1gebA-4y9vA:19.01"],["1HTT_D_HISD450_0","HISTIDYL-TRNA SYNTHETASE","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",5,"THR A 456;ARG A 268;ARG A 401;GLY A 435;ALA A 405","None;SO4 A 809 ( 3.1A);SO4 A 809 (-2.9A);None;None","1.04A","1httD-4y9vA:undetectable","1httD-4y9vA:21.73"],["1KF6_N_ACTN803_0","FUMARATE REDUCTASE FLAVOPROTEIN;FUMARATE REDUCTASE IRON-SULFUR PROTEIN","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",4,"ARG A 357;GLY A 410;ASP A 409;TYR A 257","None;49T A 815 ( 4.5A);None;None","1.45A","1kf6M-4y9vA:undetectable;1kf6N-4y9vA:undetectable","1kf6M-4y9vA:21.58;1kf6N-4y9vA:16.77"],["1LH6_A_NIOA155_1","LEGHEMOGLOBIN A (NICOTINATE MET)","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",4,"PHE A 198;PHE A 200;PHE A 208;VAL A 171","None","1.01A","1lh6A-4y9vA:undetectable","1lh6A-4y9vA:14.65"],["1LH6_A_NIOA155_1","LEGHEMOGLOBIN A (NICOTINATE MET)","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",4,"PHE A 200;PHE A 208;PHE A 216;VAL A 171","None","0.98A","1lh6A-4y9vA:undetectable","1lh6A-4y9vA:14.65"],["1NW5_A_SAMA401_0","MODIFICATION METHYLASE RSRI","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",5,"ASP A 568;PRO A 500;GLY A 537;VAL A 539;ALA A 569","None","1.31A","1nw5A-4y9vA:undetectable","1nw5A-4y9vA:19.61"],["2CIZ_A_ACTA1321_0","CHLOROPEROXIDASE","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",4,"LEU A 427;ASN A 397;VAL A 422;ALA A 425","None","1.19A","2cizA-4y9vA:undetectable","2cizA-4y9vA:19.50"],["2DCF_A_ACAA502_1","6-AMINOHEXANOATE-DIMER HYDROLASE","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",5,"ALA A 403;TYR A 392;VAL A 422;GLY A 381;ILE A 382","None","1.21A","2dcfA-4y9vA:undetectable","2dcfA-4y9vA:20.09"],["2FQY_A_ADNA400_1","MEMBRANE LIPOPROTEIN TMPC","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",5,"ASP A 461;PHE A 488;GLY A 460;MET A 438;VAL A 478","EDO A 802 (-4.0A);None;EDO A 802 ( 3.8A);None;None","1.39A","2fqyA-4y9vA:undetectable","2fqyA-4y9vA:21.34"],["2JFA_B_CCSB417_0","ESTROGEN RECEPTOR","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",3,"GLN A 170;LYS A 172;VAL A 176","EDO A 804 (-4.1A);None;EDO A 808 ( 3.6A)","0.75A","2jfaB-4y9vA:undetectable","2jfaB-4y9vA:15.10"],["2LH6_A_NIOA155_1","LEGHEMOGLOBIN A (NICOTINATE MET)","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",4,"PHE A 198;PHE A 200;PHE A 208;VAL A 171","None","1.02A","2lh6A-4y9vA:undetectable","2lh6A-4y9vA:14.65"],["2VL2_A_BEZA1162_0","PEROXIREDOXIN-5","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",5,"THR A 497;GLY A 476;LEU A 570;PHE A 567;GLY A 537","None","1.31A","2vl2A-4y9vA:undetectable;2vl2C-4y9vA:undetectable","2vl2A-4y9vA:14.22;2vl2C-4y9vA:14.22"],["2ZJ0_C_2FAC500_2","ADENOSYLHOMOCYSTEINASE","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",4,"LEU A 501;THR A 497;THR A 540;HIS A 572","None","1.32A","2zj0C-4y9vA:undetectable","2zj0C-4y9vA:21.40"],["3A65_A_ACAA601_1","6-AMINOHEXANOATE-DIMER HYDROLASE","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",5,"ALA A 403;TYR A 392;VAL A 422;GLY A 381;ILE A 382","None","1.37A","3a65A-4y9vA:undetectable","3a65A-4y9vA:20.09"],["3APV_A_TP0A190_1","ALPHA-1-ACID GLYCOPROTEIN 2","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",5,"VAL A 176;PHE A 216;PHE A 208;LEU A 318;HIS A 180","EDO A 808 ( 3.6A);None;None;None;EDO A 805 (-4.6A)","1.37A","3apvA-4y9vA:undetectable","3apvA-4y9vA:14.22"],["3APV_B_TP0B190_1","ALPHA-1-ACID GLYCOPROTEIN 2","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",5,"VAL A 176;PHE A 216;PHE A 208;LEU A 318;HIS A 180","EDO A 808 ( 3.6A);None;None;None;EDO A 805 (-4.6A)","1.36A","3apvB-4y9vA:undetectable","3apvB-4y9vA:14.22"],["3EKP_B_478B200_2","PROTEASE","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",5,"LEU A 354;VAL A 404;GLY A 394;ALA A 369;ILE A 382","None","0.97A","3ekpB-4y9vA:undetectable","3ekpB-4y9vA:8.44"],["3EL0_A_1UNA201_2","PROTEASE;PROTEASE","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",5,"LEU A 354;VAL A 404;GLY A 394;ALA A 369;ILE A 382","None","1.02A","3el0B-4y9vA:undetectable","3el0B-4y9vA:8.44"],["3IK6_B_HCZB262_1","GLUTAMATE RECEPTOR 2;GLUTAMATE RECEPTOR 2","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",5,"ILE A 724;PRO A 656;SER A 722;GLY A 723;LYS A 654","None","1.31A","3ik6B-4y9vA:undetectable;3ik6E-4y9vA:undetectable","3ik6B-4y9vA:16.01;3ik6E-4y9vA:16.01"],["3IK6_B_HCZB800_1","GLUTAMATE RECEPTOR 2;GLUTAMATE RECEPTOR 2","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",5,"LYS A 654;ILE A 724;PRO A 656;SER A 722;GLY A 723","None","1.28A","3ik6B-4y9vA:undetectable;3ik6E-4y9vA:undetectable","3ik6B-4y9vA:16.01;3ik6E-4y9vA:16.01"],["3OWX_A_XRAA233_2","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE];RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",4,"VAL A 304;PHE A 240;ILE A 232;PHE A 289","None","1.13A","3owxB-4y9vA:undetectable","3owxB-4y9vA:16.45"],["3SUF_B_SUEB1201_3","NS3 PROTEASE, NS4A PROTEIN;NS3 PROTEASE, NS4A PROTEIN","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",4,"SER A 385;PRO A 416;TYR A 271;VAL A 415","None","1.41A","3sufC-4y9vA:undetectable","3sufC-4y9vA:16.00"],["3TWP_A_SALA404_1","ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",4,"ASN A 598;ALA A 603;PRO A 605;ARG A 571","None","1.08A","3twpA-4y9vA:undetectable","3twpA-4y9vA:21.31"],["4MMD_A_29EA603_1","TRANSPORTER","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",5,"VAL A 404;ALA A 405;GLY A 420;SER A 385;GLY A 407","None;None;None;None;49S A 814 (-3.5A)","1.22A","4mmdA-4y9vA:undetectable","4mmdA-4y9vA:20.38"],["4MMD_B_29EB603_1","TRANSPORTER","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",5,"VAL A 404;ALA A 405;GLY A 420;SER A 385;GLY A 407","None;None;None;None;49S A 814 (-3.5A)","1.19A","4mmdB-4y9vA:undetectable","4mmdB-4y9vA:20.38"],["4N48_B_SAMB601_1","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",4,"ASN A 441;GLY A 407;ASP A 448;ASP A 437","49S A 814 (-3.6A);49S A 814 (-3.5A);None;SO4 A 809 ( 4.7A)","1.15A","4n48B-4y9vA:undetectable","4n48B-4y9vA:22.60"],["4N49_A_SAMA601_1","CAP-SPECIFIC MRNA (NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",4,"ASN A 441;GLY A 407;ASP A 448;ASP A 437","49S A 814 (-3.6A);49S A 814 (-3.5A);None;SO4 A 809 ( 4.7A)","1.12A","4n49A-4y9vA:undetectable","4n49A-4y9vA:22.60"],["4WOZ_B_MN9B401_0","N-ACETYLNEURAMINATE LYASE","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",4,"THR A 206;LEU A 149;ASP A 150;LEU A 179","None;None;EDO A 807 ( 3.6A);None","0.74A","4wozA-4y9vA:undetectable;4wozB-4y9vA:undetectable","4wozA-4y9vA:18.28;4wozB-4y9vA:18.28"],["4WOZ_F_MN9F401_0","N-ACETYLNEURAMINATE LYASE","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",4,"LEU A 149;ASP A 150;LEU A 179;THR A 206","None;EDO A 807 ( 3.6A);None;None","0.75A","4wozF-4y9vA:undetectable;4wozH-4y9vA:undetectable","4wozF-4y9vA:18.28;4wozH-4y9vA:18.28"],["4XE5_A_OBNA1104_2","SODIUM\/POTASSIUM-TRANSPORTING ATPASE SUBUNIT ALPHA-1","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",4,"PRO A 483;ILE A 510;VAL A 576;ARG A 472","None","1.07A","4xe5A-4y9vA:undetectable","4xe5A-4y9vA:20.23"],["4XUM_A_IMNA501_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",5,"ILE A 311;PHE A 362;LEU A 356;LEU A 354;LEU A 331","EDO A 803 (-4.6A);None;None;None;None","1.32A","4xumA-4y9vA:undetectable","4xumA-4y9vA:17.97"],["4Y8W_C_STRC603_1","CYTOCHROME P450 21-HYDROXYLASE","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",5,"SER A 505;TRP A 575;ILE A 591;ILE A 541;GLY A 509","None","0.93A","4y8wC-4y9vA:undetectable","4y8wC-4y9vA:20.68"],["5KQX_A_ROCA101_2","PROTEASE E35D-SQV;PROTEASE E35D-SQV","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",5,"LEU A 354;VAL A 404;GLY A 395;ILE A 366;ILE A 382","None","1.13A","5kqxB-4y9vA:undetectable","5kqxB-4y9vA:9.77"],["5OEX_A_CUA601_0","THIOCYANATE DEHYDROGENASE","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",3,"HIS A 439;ASP A 437;HIS A 402","49S A 814 ( 3.4A);SO4 A 809 ( 4.7A);SO4 A 809 (-3.9A)","0.71A","5oexA-4y9vA:undetectable","5oexA-4y9vA:21.36"],["5OEX_B_CUB601_0","THIOCYANATE DEHYDROGENASE","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",3,"HIS A 439;ASP A 437;HIS A 402","49S A 814 ( 3.4A);SO4 A 809 ( 4.7A);SO4 A 809 (-3.9A)","0.74A","5oexB-4y9vA:undetectable","5oexB-4y9vA:21.36"],["5OEX_D_CUD601_0","THIOCYANATE DEHYDROGENASE","4y9v","PARTICLE-ASSOCIATED LYASE","Acinetobacter virus AP22",3,"HIS A 439;ASP A 437;HIS A 402","49S A 814 ( 3.4A);SO4 A 809 ( 4.7A);SO4 A 809 (-3.9A)","0.76A","5oexD-4y9vA:undetectable","5oexD-4y9vA:21.36"]]